Literature DB >> 24591921

Ultrasound findings in aneuploidy fetusus: Evaluation of 332 cases.

Ahmet Yalınkaya1, Ali İrfan Güzel1, Kadir Kangal1, Ayşegül Türkyılmaz2, Zelal Savaş1.   

Abstract

OBJECTIVE: To evaluate the ultrasound findings found on ultrasound examination among cases that had aneuploidy at amniocentesis.
MATERIAL AND METHODS: This prospective study was performed at Dicle University, School of Medicine, Department of Obstetrics and Gynecology. 332 cases applied to our department for prenatal diagnosis and amniocentesis (AC) was performed. Of these cases, twenty were found to have aneuploidy evaluated. The factors recorded were; mean age, gestational weeks, AC indications, ultrasound findings (by Toshiba 140A and GE Voluson 730 Pro 4D ultrasound device) and fetal anomalies.
RESULTS: 332 cases have had AC by an experienced specialist, in a two year period. The mean age of the cases was 32.20±6.03 years (22-44), and gestational weeks 16.45±1.46 (13-19). AC indications were; high double and/or triple test with ultrasound findings and abnormal ultrasound findings. In 8 (2.40%) cases there was no reproduction on cell culture. In 14 (4.21%) cases, different types of chromosomal anomalies were detected. In these cases, peripheral blood was taken from the parents and if, at least in one of them this situation was present, this would be accepted as normal. In 20 (6.02%) cases aneuploidy (numerical chromosomal anomalies) were detected and 11 of them (55.00%) were trisomy 21. In all of these aneuploidy cases, different types of ultrasound findings were detected; most of them had multiple ultrasound findings, and some of them had one anomaly. Of all 20 aneuploidy cases; termination of pregnancy was decided in 17 (85%) of them. 3 (15%) of these cases decided to carry on their pregnancy. Of the 3 cases; one baby was delivered spontaneously and live, one had died in utero and labor was induced and the third pregnancy is ongoing.
CONCLUSION: The importance of ultrasound in fetal anomaly screening is incontrovertible and positive ultrasound findings are the most important indications of amniocentesis. For this reason, before amniocentesis, we advise a detailed ultrasound examination by an experienced specialist.

Entities:  

Keywords:  Amniocentesis; aneuploidy; ultrasound findings

Year:  2010        PMID: 24591921      PMCID: PMC3939222          DOI: 10.5152/jtgga.2010.22

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  12 in total

1.  Ultrasonographically detectable markers of fetal chromosomal abnormalities.

Authors:  K H Nicolaides; R J Snijders; C M Gosden; C Berry; S Campbell
Journal:  Lancet       Date:  1992-09-19       Impact factor: 79.321

2.  A comparative study of routine versus selective fetal anomaly ultrasound scanning.

Authors:  G Long; A Sprigg
Journal:  J Med Screen       Date:  1998       Impact factor: 2.136

3.  Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.

Authors:  N J Wald; A K Hackshaw
Journal:  Prenat Diagn       Date:  1997-09       Impact factor: 3.050

4.  [First trimester ultrasound: an early screening tool for fetal structural and chromosomal abnormalities].

Authors:  Dalenda Chelli; Inès Gaddour; Inès Najar; Fethia Boudaya; Béchir Zouaoui; Ezzeddine Sfar; Habiba Chaabouni; Hèla Chelli; Channoufi Mohamed
Journal:  Tunis Med       Date:  2009-12

5.  A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.

Authors:  K Spencer; V Souter; N Tul; R Snijders; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  1999-04       Impact factor: 7.299

6.  Changing trends in patient decisions concerning genetic amniocentesis.

Authors:  C C Kocun; J T Harrigan; J C Canterino; S M Feld; C O Fernandez
Journal:  Am J Obstet Gynecol       Date:  2000-05       Impact factor: 8.661

7.  The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester.

Authors:  Bryann Bromley; Ellice Lieberman; Thomas D Shipp; Beryl R Benacerraf
Journal:  J Ultrasound Med       Date:  2002-10       Impact factor: 2.153

8.  Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial.

Authors:  A Saari-Kemppainen; O Karjalainen; P Ylöstalo; O P Heinonen
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

9.  ACOG Practice Bulletin No. 88, December 2007. Invasive prenatal testing for aneuploidy.

Authors: 
Journal:  Obstet Gynecol       Date:  2007-12       Impact factor: 7.661

10.  RETIRED: Prenatal screening for fetal aneuploidy.

Authors:  Anne M Summers; Sylvie Langlois; Phil Wyatt; R Douglas Wilson
Journal:  J Obstet Gynaecol Can       Date:  2007-02
View more
  1 in total

1.  The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester.

Authors:  Ozlem Ozer; Cenk N Sayın; Füsun G Varol
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.